What is Freenome?
 
Freenome is a revolutionary AI platform that specializes in analyzing blood samples for the early detection of cancer and other diseases. The platform uses advanced machine learning algorithms to process genomic, proteomic, and epigenomic data to identify biomarkers associated with disease. Freenome's technology enables proactive healthcare by providing healthcare professionals with actionable insights that can guide early intervention and treatment. The platform supports various applications, including cancer screening, disease monitoring, and risk assessment. Freenome collaborates with healthcare providers and research institutions to advance early detection research and improve patient care. Overall, Freenome is a valuable tool for healthcare organizations seeking to leverage AI technology to enhance early detection and improve patient outcomes.